Safety and Efficacy Study of Albiglutide in Type 2 Diabetes

Clinical trial NCT00849017 · COMPLETED

Trial details

NCT number: NCT00849017
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2009-01-01
Primary completion: 2011-11-01
Enrollment: 309

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.